Baccine
Baccine

Baccine

DR5Ahrefs DR: 5/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

2022Inactive9Boston, United States

About

Baccine is a biotechnology startup focused on developing novel bacteria-based immunotherapy treatments. Their approach aims to enhance the body's anti-tumor immune response, offering potentially more effective and targeted treatment options for cancer patients.

Key facts

At-a-glance profile data

Website
baccine.tech
Headquarters
Boston, United States
Founded
2022
Employees
9
Total funding
-
Business model
B2B

Tech stack

Detected on baccine.tech, last scanned 5 Jun 2026. Run your own scan

Hosting
Google Cloud
Email provider
Microsoft 365
Add first review

Frequently asked

How many employees does Baccine have?

Baccine has approximately 9 people on record.

What is Baccine's current status?

Baccine's current operating status is: Inactive.